Aprea Therapeutics Inc. (APRE) NASDAQ
$5.36 (0.45) (-7.67%)
Market Cap: $31.50M
As of 05/16/24 01:19 PM EDT. Market open.
Aprea Therapeutics Inc. (APRE)
NASDAQ
$5.36
(0.45) (-7.67%)
Market Cap: $31.50M
As of 05/16/24 01:19 PM EDT. Market open.
Add to Portfolio
annan naturvetenskaplig och teknisk forskning och ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
3
URL
Address
.
PRICE CHART FOR APREA THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$5.85
Previous Close
$5.80
Days Range
$5.56 - $5.88
52 week range
$2.78 - $8.85
Volume
14,114
Avg. Volume (30 days)
7,598
Market Cap
$31.50M
Dividend Yield
-
P/E
-
Shares Outstanding
5,430,215
Open
$5.85
Previous Close
$5.80
Days Range
$5.56 - $5.88
52 week range
$2.78 - $8.85
Volume
14,114
Avg. Volume (30 days)
7,598
Market Cap
$31.50M
Dividend Yield
-
P/E
-
Shares Outstanding
5,430,215
FINANCIAL STATEMENTS FOR APREA THERAPEUTICS INC
LOADING...
INSIDER TRANSACTIONS FOR APREA THERAPEUTICS INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | Mar 13, 2024 | Buy | $7.29 | 1,010 | 7,363 | 15,503 | Mar 14, 2024, 08:54 PM |
Seizinger Bernd R. | Director | Mar 13, 2024 | Buy | $7.29 | 6,860 | 50,009 | 33,685 | Mar 14, 2024, 08:53 PM |
HENNEMAN JOHN B III | Director | Mar 13, 2024 | Buy | $7.29 | 6,860 | 50,009 | 8,139 | Mar 14, 2024, 08:52 PM |
Gilad Oren | President, CEO | Mar 13, 2024 | Buy | $7.29 | 2,000 | 14,580 | 324,770 | Mar 14, 2024, 08:51 PM |
Seizinger Bernd R. | Director | Jun 07, 2023 | Buy | $3.68 | 6,029 | 22,192 | 26,325 | Jun 08, 2023, 04:34 PM |
Seizinger Bernd R. | Director | Jun 06, 2023 | Buy | $3.63 | 4,068 | 14,764 | 20,296 | Jun 08, 2023, 04:34 PM |
Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | Feb 27, 2023 | Option Exercise | $5.25 | 1,000 | 5,250 | 14,493 | Feb 27, 2023, 06:37 PM |
SCHADE CHRISTIAN S | Chairman & CEO | Jun 03, 2022 | Option Exercise | $0.81 | 65,770 | 52,945 | 226,846 | Jun 07, 2022, 05:05 PM |
Coiante Scott M | SVP, Chief Financial Officer | Jun 03, 2022 | Option Exercise | $0.81 | 35,284 | 28,404 | 84,265 | Jun 07, 2022, 05:02 PM |
Korbel Gregory Alan | SVP, Chief Operating Officer | Jun 03, 2022 | Option Exercise | $0.81 | 8,390 | 6,754 | 21,462 | Jun 07, 2022, 05:01 PM |
Attar Eyal C. | SVP, Chief Medical Officer | Jun 03, 2022 | Option Exercise | $0.81 | 32,667 | 26,297 | 57,233 | Jun 07, 2022, 05:00 PM |
Seizinger Bernd R. | Director | May 18, 2022 | Buy | $0.71 | 50,000 | 35,500 | 318,580 | May 19, 2022, 04:31 PM |
SCHADE CHRISTIAN S | Chairman & CEO | May 18, 2022 | Buy | $0.64 | 37,500 | 24,124 | 292,616 | May 19, 2022, 04:30 PM |
Korbel Gregory Alan | SVP, Chief Business Officer | Mar 10, 2022 | Option Exercise | $1.82 | 1,989 | 3,620 | 29,852 | Mar 14, 2022, 05:03 PM |
SCHADE CHRISTIAN S | Chairman & CEO | Feb 25, 2022 | Option Exercise | $1.74 | 21,644 | 37,661 | 155,016 | Mar 01, 2022, 05:02 PM |
Korbel Gregory Alan | SVP, Chief Business Officer | Feb 25, 2022 | Option Exercise | $1.74 | 1,326 | 2,307 | 15,841 | Mar 01, 2022, 05:02 PM |
Coiante Scott M | SVP, Chief Financial Officer | Feb 25, 2022 | Option Exercise | $1.74 | 14,817 | 25,782 | 76,649 | Mar 01, 2022, 05:01 PM |
Attar Eyal C. | SVP, Chief Medical Officer | Feb 28, 2022 | Sale | $1.73 | 36,000 | 62,280 | 47,000 | Mar 01, 2022, 05:01 PM |
Korbel Gregory Alan | SVP, Chief Business Officer | Dec 01, 2021 | Option Exercise | $0.92 | 27,500 | 25,300 | 44,667 | Dec 03, 2021, 05:01 PM |
Korbel Gregory Alan | SVP, Chief Business Officer | Dec 01, 2021 | Sale | $3.96 | 27,500 | 108,900 | 17,167 | Dec 03, 2021, 05:01 PM |
Korbel Gregory Alan | SVP, Chief Business Officer | Nov 01, 2021 | Option Exercise | $0.92 | 27,500 | 25,300 | 44,667 | Nov 03, 2021, 05:34 PM |
Korbel Gregory Alan | SVP, Chief Business Officer | Nov 01, 2021 | Sale | $5.00 | 27,500 | 137,500 | 17,167 | Nov 03, 2021, 05:34 PM |
Abrahmsen Lars B. | SVP, Chief Scientific Officer | Oct 01, 2021 | Option Exercise | $0.92 | 50,000 | 46,000 | 69,000 | Oct 05, 2021, 05:01 PM |
Abrahmsen Lars B. | SVP, Chief Scientific Officer | Oct 01, 2021 | Sale | $4.89 | 50,000 | 244,500 | 19,000 | Oct 05, 2021, 05:01 PM |
Korbel Gregory Alan | SVP, Chief Business Officer | Oct 01, 2021 | Option Exercise | $0.92 | 27,500 | 25,300 | 44,667 | Oct 05, 2021, 05:01 PM |
Korbel Gregory Alan | SVP, Chief Business Officer | Oct 01, 2021 | Sale | $4.89 | 27,500 | 134,475 | 17,167 | Oct 05, 2021, 05:01 PM |
Korbel Gregory Alan | SVP, Chief Business Officer | Sep 20, 2021 | Option Exercise | $0.92 | 27,500 | 25,300 | 44,667 | Sep 22, 2021, 05:01 PM |
Korbel Gregory Alan | SVP, Chief Business Officer | Sep 20, 2021 | Sale | $4.97 | 32,960 | 163,866 | 17,167 | Sep 22, 2021, 05:01 PM |
Abrahmsen Lars B. | SVP, Chief Scientific Officer | Sep 20, 2021 | Option Exercise | $0.92 | 25,000 | 23,000 | 44,000 | Sep 22, 2021, 05:00 PM |
Abrahmsen Lars B. | SVP, Chief Scientific Officer | Sep 20, 2021 | Sale | $4.97 | 25,000 | 124,250 | 19,000 | Sep 22, 2021, 05:00 PM |
Attar Eyal C. | SVP, Chief Medical Officer | Sep 16, 2021 | Sale | $4.68 | 15,968 | 74,730 | 83,000 | Sep 20, 2021, 05:29 PM |
Korbel Gregory Alan | Chief Business Officer | Sep 10, 2021 | Option Exercise | $4.59 | 1,724 | 7,913 | 22,627 | Sep 14, 2021, 05:01 PM |
Korbel Gregory Alan | Chief Business Officer | Aug 25, 2021 | Option Exercise | $3.98 | 1,149 | 4,573 | 24,351 | Aug 27, 2021, 05:02 PM |
Coiante Scott M | SVP, Chief Financial Officer | Aug 25, 2021 | Option Exercise | $3.98 | 7,534 | 29,985 | 91,466 | Aug 27, 2021, 05:01 PM |
Attar Eyal C. | SVP, Chief Medical Officer | Aug 25, 2021 | Option Exercise | $3.98 | 9,032 | 35,947 | 98,968 | Aug 27, 2021, 05:00 PM |
Redmile Group, LLC | 10% Owner | Dec 28, 2020 | Sale | $5.58 | 500,000 | 2,791,290 | 1,774,581 | Feb 16, 2021, 04:11 PM |
5AM Ventures IV, L.P. | Former 10% holder | Oct 05, 2020 | Sale | $25.30 | 175,000 | 4,427,500 | 138,497 | Oct 07, 2020, 09:30 PM |
KDev Investments AB | 10% Owner | Jul 07, 2020 | Sale | $34.55 | 241,703 | 8,350,838 | 1,992,586 | Jul 07, 2020, 05:41 PM |
ROCKLAGE SCOTT M | Director | Jun 16, 2020 | Sale | $33.30 | 120,164 | 4,001,461 | 1,823,192 | Jun 18, 2020, 07:23 PM |
5AM Ventures IV, L.P. | 10% Owner | Jun 16, 2020 | Sale | $33.30 | 140,000 | 4,662,000 | 1,823,192 | Jun 18, 2020, 07:22 PM |
ROCKLAGE SCOTT M | Director | Jun 11, 2020 | Sale | $28.75 | 245,000 | 7,044,412 | 1,938,549 | Jun 15, 2020, 09:13 PM |
5AM Ventures IV, L.P. | 10% Owner | Jun 11, 2020 | Sale | $28.75 | 245,000 | 7,044,412 | 1,938,549 | Jun 15, 2020, 09:12 PM |
ROCKLAGE SCOTT M | Director | May 19, 2020 | Sale | $35.15 | 255,000 | 8,963,250 | 2,173,748 | May 21, 2020, 09:32 PM |
5AM Ventures IV, L.P. | 10% Owner | May 19, 2020 | Sale | $35.15 | 255,000 | 8,963,250 | 2,173,748 | May 21, 2020, 09:31 PM |
KDev Investments AB | 10% Owner | Apr 13, 2020 | Sale | $31.25 | 210,548 | 6,579,625 | 2,234,289 | Apr 15, 2020, 09:18 AM |
5AM Ventures IV, L.P. | 10% Owner | Oct 07, 2019 | Buy | $15.00 | 333,333 | 4,999,995 | 333,333 | Oct 09, 2019, 06:23 PM |
Redmile Group, LLC | 10% Owner | Oct 07, 2019 | Buy | $15.00 | 400,000 | 6,000,000 | 2,268,718 | Oct 08, 2019, 08:13 PM |
HealthCap VII, L.P. | 10% Owner | Oct 07, 2019 | Buy | $15.00 | 266,667 | 4,000,005 | 2,366,104 | Oct 07, 2019, 07:53 PM |
Versant Vantage I, L.P. | 10% Owner | Oct 07, 2019 | Buy | $15.00 | 333,333 | 4,999,995 | 333,333 | Oct 07, 2019, 07:40 PM |
Versant V Luxco S.a r.l. | 10% Owner | Oct 07, 2019 | Buy | $15.00 | 333,333 | 4,999,995 | 333,333 | Oct 07, 2019, 07:39 PM |
Christenson Johan | Director | Oct 07, 2019 | Buy | $15.00 | 266,667 | 4,000,005 | 2,366,104 | Oct 07, 2019, 07:33 PM |
Seizinger Bernd R. | Director | Oct 07, 2019 | Option Exercise | $0.07 | 263,970 | 18,478 | 263,970 | Oct 07, 2019, 07:33 PM |
Magni Guido | Director | Oct 07, 2019 | Buy | $15.00 | 6,500 | 97,500 | 6,500 | Oct 07, 2019, 07:25 PM |
HENNEMAN JOHN B III | Director | Oct 07, 2019 | Buy | $15.00 | 5,000 | 75,000 | 5,000 | Oct 07, 2019, 07:23 PM |
Korbel Gregory Alan | VP of Business Dev't | Oct 07, 2019 | Buy | $15.00 | 500 | 7,500 | 500 | Oct 07, 2019, 07:21 PM |
Attar Eyal C. | SVP, Chief Medical Officer | Oct 07, 2019 | Buy | $15.00 | 200 | 3,000 | 200 | Oct 07, 2019, 07:18 PM |
Attar Eyal C. | SVP, Chief Medical Officer | Oct 07, 2019 | Buy | $15.00 | 200 | 3,000 | 200 | Oct 07, 2019, 07:18 PM |
Coiante Scott M | SVP, Chief Financial Officer | Oct 07, 2019 | Buy | $15.00 | 2,500 | 37,500 | 2,500 | Oct 07, 2019, 07:15 PM |
SCHADE CHRISTIAN S | President & CEO | Oct 07, 2019 | Buy | $15.00 | 5,000 | 75,000 | 5,000 | Oct 07, 2019, 07:15 PM |
SCHADE CHRISTIAN S | President & CEO | Oct 07, 2019 | Buy | $15.00 | 6,000 | 90,000 | 1,000 | Oct 07, 2019, 07:15 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | 03/13/2024 | 7,363 |
Seizinger Bernd R. | Director | 03/13/2024 | 50,009 |
HENNEMAN JOHN B III | Director | 03/13/2024 | 50,009 |
Gilad Oren | President, CEO | 03/13/2024 | 14,580 |
Seizinger Bernd R. | Director | 06/07/2023 | 22,192 |
Seizinger Bernd R. | Director | 06/06/2023 | 14,764 |
Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | 02/27/2023 | 5,250 |
SCHADE CHRISTIAN S | Chairman & CEO | 06/03/2022 | 52,945 |
Coiante Scott M | SVP, Chief Financial Officer | 06/03/2022 | 28,404 |
Korbel Gregory Alan | SVP, Chief Operating Officer | 06/03/2022 | 6,754 |
Attar Eyal C. | SVP, Chief Medical Officer | 06/03/2022 | 26,297 |
Seizinger Bernd R. | Director | 05/18/2022 | 35,500 |
SCHADE CHRISTIAN S | Chairman & CEO | 05/18/2022 | 24,124 |
Korbel Gregory Alan | SVP, Chief Business Officer | 03/10/2022 | 3,620 |
SCHADE CHRISTIAN S | Chairman & CEO | 02/25/2022 | 37,661 |
Korbel Gregory Alan | SVP, Chief Business Officer | 02/25/2022 | 2,307 |
Coiante Scott M | SVP, Chief Financial Officer | 02/25/2022 | 25,782 |
Attar Eyal C. | SVP, Chief Medical Officer | 02/28/2022 | 62,280 |
Korbel Gregory Alan | SVP, Chief Business Officer | 12/01/2021 | 25,300 |
Korbel Gregory Alan | SVP, Chief Business Officer | 12/01/2021 | 108,900 |
Korbel Gregory Alan | SVP, Chief Business Officer | 11/01/2021 | 25,300 |
Korbel Gregory Alan | SVP, Chief Business Officer | 11/01/2021 | 137,500 |
Abrahmsen Lars B. | SVP, Chief Scientific Officer | 10/01/2021 | 46,000 |
Abrahmsen Lars B. | SVP, Chief Scientific Officer | 10/01/2021 | 244,500 |
Korbel Gregory Alan | SVP, Chief Business Officer | 10/01/2021 | 25,300 |
Korbel Gregory Alan | SVP, Chief Business Officer | 10/01/2021 | 134,475 |
Korbel Gregory Alan | SVP, Chief Business Officer | 09/20/2021 | 25,300 |
Korbel Gregory Alan | SVP, Chief Business Officer | 09/20/2021 | 163,866 |
Abrahmsen Lars B. | SVP, Chief Scientific Officer | 09/20/2021 | 23,000 |
Abrahmsen Lars B. | SVP, Chief Scientific Officer | 09/20/2021 | 124,250 |
Attar Eyal C. | SVP, Chief Medical Officer | 09/16/2021 | 74,730 |
Korbel Gregory Alan | Chief Business Officer | 09/10/2021 | 7,913 |
Korbel Gregory Alan | Chief Business Officer | 08/25/2021 | 4,573 |
Coiante Scott M | SVP, Chief Financial Officer | 08/25/2021 | 29,985 |
Attar Eyal C. | SVP, Chief Medical Officer | 08/25/2021 | 35,947 |
Redmile Group, LLC | 10% Owner | 12/28/2020 | 2,791,290 |
5AM Ventures IV, L.P. | Former 10% holder | 10/05/2020 | 4,427,500 |
KDev Investments AB | 10% Owner | 07/07/2020 | 8,350,838 |
ROCKLAGE SCOTT M | Director | 06/16/2020 | 4,001,461 |
5AM Ventures IV, L.P. | 10% Owner | 06/16/2020 | 4,662,000 |
ROCKLAGE SCOTT M | Director | 06/11/2020 | 7,044,412 |
5AM Ventures IV, L.P. | 10% Owner | 06/11/2020 | 7,044,412 |
ROCKLAGE SCOTT M | Director | 05/19/2020 | 8,963,250 |
5AM Ventures IV, L.P. | 10% Owner | 05/19/2020 | 8,963,250 |
KDev Investments AB | 10% Owner | 04/13/2020 | 6,579,625 |
5AM Ventures IV, L.P. | 10% Owner | 10/07/2019 | 4,999,995 |
Redmile Group, LLC | 10% Owner | 10/07/2019 | 6,000,000 |
HealthCap VII, L.P. | 10% Owner | 10/07/2019 | 4,000,005 |
Versant Vantage I, L.P. | 10% Owner | 10/07/2019 | 4,999,995 |
Versant V Luxco S.a r.l. | 10% Owner | 10/07/2019 | 4,999,995 |
Christenson Johan | Director | 10/07/2019 | 4,000,005 |
Seizinger Bernd R. | Director | 10/07/2019 | 18,478 |
Magni Guido | Director | 10/07/2019 | 97,500 |
HENNEMAN JOHN B III | Director | 10/07/2019 | 75,000 |
Korbel Gregory Alan | VP of Business Dev't | 10/07/2019 | 7,500 |
Attar Eyal C. | SVP, Chief Medical Officer | 10/07/2019 | 3,000 |
Attar Eyal C. | SVP, Chief Medical Officer | 10/07/2019 | 3,000 |
Coiante Scott M | SVP, Chief Financial Officer | 10/07/2019 | 37,500 |
SCHADE CHRISTIAN S | President & CEO | 10/07/2019 | 75,000 |
SCHADE CHRISTIAN S | President & CEO | 10/07/2019 | 90,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN APREA THERAPEUTICS INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
GEODE CAPITAL MANAGEMENT, LLC | 20,221 | 0.00001% | 15.73% | Other |
BLACKROCK INC. | 8,504 | 0% | No change | Other |
CHANGE IN SHARES OUTSTANDING FOR APREA THERAPEUTICS INC
STOCK BUYBACKS FOR APREA THERAPEUTICS INC
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.08%
1Q
06/30/2023
0.17%
2Q
03/31/2023
14.65%
3Q
BUYBACK ANNOUNCEMENT(S) FOR APREA THERAPEUTICS INC
LOADING...